New sales order for 593 kSEK (51 kEUR) for a Bilberry extract
Eevia Health Plc (”Eevia” or ”The Company”) has received a sales order for 51 kEUR (593 kSEK) from a German customer for Feno-Myrtillus 36 organic, an organically certified bilberry extract.
Eevia received the sales order from a German customer but with delivery to a local Finnish contract manufacturer. The product is therefore not an export revenue, but sales within Finland. Thes sales value to Eevia is c. 51 kEUR. The product is Eevia’s branded ingredient Feno-Myrtillus® 36 Organic.
The customer also communicated forthcoming orders for approximately 110 kEUR for Q3-24.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: [email protected] or [email protected]
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.
